Credit Suisse’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

Credit Suisse’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,645	Closed	-$11.1K	–	3494
2022 Q4	$11.1K	Sell	2,645 -18,920	-88%	-$71.6K	﹤0.01%	3502
2022 Q3	$86K	Sell	21,565 -2,039	-9%	-$15.5K	﹤0.01%	3472
2022 Q2	$267K	Sell	23,604 -56,173	-70%	-$673K	﹤0.01%	3215
2022 Q1	$1.29M	Buy	79,777 +5,198	+7%	+$133K	﹤0.01%	2364
2021 Q4	$3.54M	Buy	74,579 +19,481	+35%	+$1.17M	﹤0.01%	2313
2021 Q3	$4M	Buy	55,098 +12,187	+28%	+$881K	﹤0.01%	2246
2021 Q2	$3.6M	Buy	+42,911	New	+$2.83M	﹤0.01%	2368
2020 Q4	–	Sell	-22,458	Closed	-$1.06M	–	4380
2020 Q3	$1.06M	Buy	+22,458	New	+$740K	﹤0.01%	2882

Other funds holding NBP

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Credit Suisse's NBP Position: Q1 2023 in Review

Credit Suisse sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q1 2023, closing a stake of 2,645 shares — an estimated $11.1K sold.

Credit Suisse first reported a position in NBP in Q3 2020 and held it in 8 quarters. The position peaked at $4M in Q3 2021. 53 funds tracked by Wall St. Rank hold NBP as of Q1 2023.

Credit Suisse reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q1 2023 after selling out during the quarter.
Credit Suisse sold 2,645 NovaBridge Biosciences American Depositary Shares shares in Q1 2023, an estimated $11.1K.
Credit Suisse first reported a position in NovaBridge Biosciences American Depositary Shares in Q3 2020 and held it in 8 quarters.
Credit Suisse's NovaBridge Biosciences American Depositary Shares position peaked at $4M in Q3 2021.
53 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q1 2023.

Based on Credit Suisse's 13F filing for Q1 2023, filed 10 May 2023.